Skip to content
10-Q

Quarterly Report

THC THERAPEUTICS, INC.

0001477932-24-005523

← back to feed
Filed
Sep 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 26, 2024 40.23M sh
Operating Cash Flow Q2 2024 · Jan 31, 2024 −$45.4K
Operating Cash Flow Q2 2024 · Jan 31, 2023 −$83.21K
Stockholders Equity Q2 2024 · Jan 31, 2024 −$3.9M
Stockholders Equity Q2 2024 · Oct 31, 2023 −$3.37M
Stockholders Equity Q2 2024 · Jul 31, 2023 −$3.31M
Stockholders Equity Q2 2024 · Jan 31, 2023 −$3.37M
Stockholders Equity Q2 2024 · Oct 31, 2022 −$5.22M
Stockholders Equity Q2 2024 · Jul 31, 2022 −$3.11M
Current Liabilities Q2 2024 · Jan 31, 2024 $3.81M
Current Liabilities Q2 2024 · Jul 31, 2023 $3.22M
Total Liabilities Q2 2024 · Jan 31, 2024 $3.81M
Total Liabilities Q2 2024 · Jul 31, 2023 $3.22M
Current Assets Q2 2024 · Jan 31, 2024 $3.51K
Current Assets Q2 2024 · Jul 31, 2023 $980
Total Assets Q2 2024 · Jan 31, 2024 $14.82K
Total Assets Q2 2024 · Jul 31, 2023 $12.99K
Net Income Q2 2024 · Jan 31, 2024 −$571.98K
Net Income Q2 2024 · Jan 31, 2024 −$634.46K
Net Income Q2 2024 · Oct 31, 2023 −$62.49K
Net Income Q2 2024 · Jan 31, 2023 $1.69M
Net Income Q2 2024 · Jan 31, 2023 −$448.45K
Net Income Q2 2024 · Oct 31, 2022 −$2.13M
Operating Income Q2 2024 · Jan 31, 2024 −$85.15K
Operating Income Q2 2024 · Jan 31, 2024 −$140.37K
Operating Income Q2 2024 · Jan 31, 2023 −$273.68K
Operating Income Q2 2024 · Jan 31, 2023 −$381.24K
Gross Profit Q2 2024 · Jan 31, 2024 $0
Gross Profit Q2 2024 · Jan 31, 2024 $0
Gross Profit Q2 2024 · Jan 31, 2023 $0
Gross Profit Q2 2024 · Jan 31, 2023 $0
Cost Of Revenue Q2 2024 · Jan 31, 2024 $0
Cost Of Revenue Q2 2024 · Jan 31, 2024 $0
Cost Of Revenue Q2 2024 · Jan 31, 2023 $0
Cost Of Revenue Q2 2024 · Jan 31, 2023 $0
Revenue Q2 2024 · Jan 31, 2024 $0
Revenue Q2 2024 · Jan 31, 2024 $0
Revenue Q2 2024 · Jan 31, 2023 $0
Revenue Q2 2024 · Jan 31, 2023 $0